Public research preview

Rob Bresnahan, Representative disclosure: Biogen Inc. - Common Stock (BIIB)

Disclosed a buy transaction in Biogen Inc. - Common Stock (BIIB). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
64/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
9 Jun 2025, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
25 days

Timeline

Transaction date

15 May 2025

Public disclosure

9 Jun 2025

Now

Tracked today

Filing delay: 25 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
24 Jul 2026

Stock path

BIIB from pre-transaction context through latest close.

Bought

15 May 2025 · 123.7 USD · Not public yet

System decision

Would have boughtThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 9 Jun 2025 at 134.15 USD. Since entry: +50.7%. Planned exit on 6 Aug 2025 after 40 trading days.

Window closed122.7169.7216.6USDDate15 May9 Jun24 JulOfficial disclosure9 JunPlanned exit134.1System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
123.7
Observed disclosure close
134.15
Observed latest close
202.19
Pre-disclosure move
+8.4%
Post-disclosure move
+50.7%
Market-adjusted move
+25.0%
1w since disclosure
-2.3%
1m since disclosure
-0.8%
3m since disclosure
+5.4%
Pre-disclosure peak run-up
+8.4%
Retrace from peak
0.0%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 9 Jun 2025, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerBIIB
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030482.pdf
personNameRob Bresnahan
amountRange$1,001 - $15,000
companyNameBiogen Inc. - Common Stock (BIIB)
publishedAt2025-06-09T00:00:00.000Z
rawDocumentIdraw-us-house-20030482-6
disclosureDate2025-06-09
transactionDate2025-05-15
transactionTypeP